[Abstract] Hepatitis B virus (HBV) can cause both acute and chronic disease in human liver with potentially high risk of cirrhosis and liver cancer. The host range of non-human primates susceptible to this virus is limited. Therefore, experimental studies with human hepatocyte-chimeric mice provide an invaluable source of information regarding the biology and pathogenesis of HBV. This section describes the protocol for infection of the human hepatocyte-chimeric mice with HBV.
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B. Infection of human hepatocyte-chimeric mice with HBV

Note: All procedures involving the manipulation of HBV infectious materials should be conducted within biological safety cabinets (BSL3).
Chimeric mice are intravenously infected with 100 μl of HBV-C in saline solution (10 6 copies per mouse) derived originally from patient with chronic hepatitis (Sugiyama et al., 2006) . Three weeks after HBV infection, the sera are prepared by collecting blood samples from the tail vein and the efficiency of infection is confirmed by measuring the number of viral genome copies in the sera of HBV-infected chimeric mice by qPCR analysis as below:
1. Prepare HBV DNA standard sample:
The HBV plasmid (pUC19-HBV, genotype A) is subjected to a 10-fold serial dilutions in
Nuclease free-H2O ranging from 1 x 10 3 to 1 x 10 9 copies/ml, and use 10 μl of this diluted sample (ranging from 1 x 10 to 1 x 10 7 copies/assay) as standard to quantification of HBV DNA.
2. Set up qPCR reaction mixtures as follows (for one sample):
DNA samples from sera of HBV-infected chimeric mice:
Nuclease free-H2O 
